CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION, USP, 75 mg/5 mL, Rx Only, 100 mL, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-603-51
Published August 19, 2026 · Recall initiated: July 30, 2026
Summary
FDA records drug Class II recall D-0768-2026, published August 19, 2026 and initiated July 30, 2026. Recalling firm: Heritage Pharmaceuticals Inc; Status: Ongoing; Lot: Lot #: 2411550, Exp. 2026/NOV. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foreign Substance: presence of particles and white flakes in the reconstituted bottles.
What to do
Voluntary: Firm initiated · Letter
Get an email if CLINDAMYCIN PALMITATE HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CLINDAMYCIN PALMITATE HYDROCHLORIDE
- Manufacturer
- Heritage Pharmaceuticals Inc
- Distributor
- Nationwide within the U.S
- Lot
- Lot #: 2411550, Exp. 2026/NOV.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACLEAR EYES Maximum Itchy Eye Relief, 0.5 fl oz (15 mL) per dropper bottle, Sterile, Dist. by Medtech ProductsAugust 19, 2026
- FDAKian Pee Wan Capsules, 30-count bottlesAugust 19, 2026
- FDASILDENAFIL CITRATE USP, 1.00KG, 1.00KG-bag Net Wt. Rx only " For Prescription Compounding Only", ShoolinAugust 19, 2026
- FDAGlutathione (MDV), 200 mg/mL, 30 mL vial, each mL contains Glutathione 200 mg, Ascorbic Acid 20 mg, BenzylAugust 19, 2026
- FDATADALAFIL USP, 1.00 KG, 1KG(1000gm)-bag, Rx only, "For Prescription Compounding Only", Shoolin Pharma ChemAugust 19, 2026
- FDAOptiray Imaging Bulk Package-350, Ioversol Injection 74%, 350 mg/mL Organically Bound Iodine, 500 mLAugust 19, 2026
Questions about this recall
Was CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION, USP, 75 mg/5 mL, Rx Only, 100 mL, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-603-51 recalled?
Yes. FDA published recall D-0768-2026 on August 19, 2026. Reported hazard: Presence of Foreign Substance: presence of particles and white flakes in the reconstituted bottles.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CLINDAMYCIN PALMITATE HYDROCHLORIDE.